Ortega Moreno, LorenaSanz García, AncorFernández de la Fuente, Marina JArroyo Solera, RicardoFernández-Tomé, SamuelMarin, Alicia CMora-Gutierrez, IreneFernández, PalomaBaldan-Martin, MontseChaparro, MaríaGisbert, Javier P.Bernardo, David2023-11-242023-11-242020Ortega Moreno, L., Sanz-Garcia, A., Fernández de la Fuente, M.J. et al. Serum adipokines as non-invasive biomarkers in Crohn’s disease. Sci Rep 10, 18027 (2020). https://doi.org/10.1038/s41598-020-74999-6https://hdl.handle.net/10115/26419Adipose tissue secretes molecules that can promote activity in Crohn’s disease. We aimed to evaluate the role of serum adipokines as possible biomarkers in Crohn’s disease. Serum samples were obtained from 40 patients with endoscopically active or quiescent Crohn’s disease and 36 healthy controls. Serum leptin, ghrelin, resistin and adiponectin levels were analysed by Multiplex in a Luminex 200 system technology. Receiver Operating Characteristic curves were performed to evaluate the adipokines discriminatory capacity. A logistic regression adjusted by possible confounders (i.e. gender, age, BMI) was performed for those adipokines that showed an area under the curve> 0.7. No diferences were found in age, gender or BMI among groups. Distribution for serum resistin was diferent among the three groups of study, and only this adipokine showed an area under the curve of 0.75 comparing actives patients and healthy control groups. Resistin median concentration was selected as a cut-of for a logistic regression analysis; odds ratio along its 95% confdence interval adjusted by gender, age, and BMI yielded a value of 5.46 (1.34–22.14) comparing actives patients and healthy controls. High concentration of serum resistin is probably associated to activity, being this association independent of gender, age or BMI.Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/article10.1038/s41598-020-74999-6info:eu-repo/semantics/openAccess